PRODUCT LITERATURE

Latanoprost for open-angle glaucoma (UKGTS): a randomised, multicentre, placebo-controlled trial

---

Treatments for open-angle glaucoma aim to prevent vision loss through lowering of intraocular pressure, but to our knowledge no placebo-controlled trials have assessed visual function preservation, and the observation periods of previous (unmasked) trials have typically been at least 5 years. We assessed vision preservation in patients
given latanoprost compared with those given placebo

---

Availability

Detail Information

Series Title

-

Call Number

-

Publisher

: .,

Collation

-

Language

English

ISBN/ISSN

-

Classification

NONE

Content Type

-

Media Type

-

Carrier Type

-

Edition

-

Subject(s)

Lacoma

Specific Detail Info

Lancet 2015; 385: 1295–304

Statement of Responsibility

-

Other version/related

File Attachment

Comments

---

You must be logged in to post a comment